BETHESDA, Md.--(BUSINESS WIRE)--BrainScope Company, Inc. today announced the publication of an independent, prospective validation study that demonstrated the potential clinical utility of its technology for the identification of acute traumatic intracranial hematomas in patients who present to hospital Emergency Departments. The results of this study, “Identification of Hematomas in Mild Traumatic Brain Injury Using an Index of Quantitative Brain Electrical Activity” appeared on-line ahead of print in the peer-reviewed Journal of Neurotrauma, authored by investigators from New York University School of Medicine and The Johns Hopkins University School of Medicine.
BrainScope’s proprietary technology records brain electrical activity with a handheld, rapid, easy-to-use, non-invasive and non-radiation emitting device. The technology utilizes advanced signal processing methods and classification algorithms that quantify and characterize features of brain electrical activity associated with traumatic brain injury (TBI).
Help employers find you! Check out all the jobs and post your resume.
